News Image

Is NASDAQ:GILD suited for dividend investing?

By Mill Chart

Last update: Nov 20, 2023

Consider GILEAD SCIENCES INC (NASDAQ:GILD) as a top pick for dividend investors, identified by our stock screening tool. NASDAQ:GILD shines in terms of profitability, solvency, and liquidity, all while paying a decent dividend. Let's dive deeper into the analysis.

Looking at the Dividend

ChartMill assigns a proprietary Dividend Rating to each stock. The score is computed by evaluating various valuation aspects, like the yield, the history, the dividend growth and sustainability. NASDAQ:GILD was assigned a score of 7 for dividend:

  • With a Yearly Dividend Yield of 4.03%, GILD is a good candidate for dividend investing.
  • GILD's Dividend Yield is rather good when compared to the industry average which is at 37.64. GILD pays more dividend than 98.83% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 2.65, GILD pays a better dividend.
  • The dividend of GILD is nicely growing with an annual growth rate of 7.27%!
  • GILD has been paying a dividend for over 5 years, so it has already some track record.
  • As GILD did not decrease their dividend in the past 5 years, we can say the dividend looks stable.

Understanding NASDAQ:GILD's Health Score

Every stock is evaluated by ChartMill, receiving a Health Rating on a scale of 0 to 10. This assessment considers different health aspects, including liquidity and solvency, both in absolute terms and relative to industry peers. NASDAQ:GILD has achieved a 5 out of 10:

  • GILD's Altman-Z score of 2.72 is fine compared to the rest of the industry. GILD outperforms 74.29% of its industry peers.
  • The Debt to FCF ratio of GILD is 3.18, which is a good value as it means it would take GILD, 3.18 years of fcf income to pay off all of its debts.
  • GILD's Debt to FCF ratio of 3.18 is amongst the best of the industry. GILD outperforms 95.33% of its industry peers.

Exploring NASDAQ:GILD's Profitability

ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of NASDAQ:GILD, the assigned 8 is noteworthy for profitability:

  • GILD has a Return On Assets of 9.42%. This is amongst the best in the industry. GILD outperforms 97.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 26.33%, GILD belongs to the top of the industry, outperforming 98.16% of the companies in the same industry.
  • GILD has a Return On Invested Capital of 12.57%. This is amongst the best in the industry. GILD outperforms 97.00% of its industry peers.
  • The last Return On Invested Capital (12.57%) for GILD is above the 3 year average (11.27%), which is a sign of increasing profitability.
  • Looking at the Profit Margin, with a value of 21.45%, GILD belongs to the top of the industry, outperforming 97.50% of the companies in the same industry.
  • With an excellent Operating Margin value of 30.16%, GILD belongs to the best of the industry, outperforming 97.50% of the companies in the same industry.
  • With an excellent Gross Margin value of 78.81%, GILD belongs to the best of the industry, outperforming 85.98% of the companies in the same industry.

Our Best Dividend screener lists more Best Dividend stocks and is updated daily.

Check the latest full fundamental report of GILD for a complete fundamental analysis.

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

GILEAD SCIENCES INC

NASDAQ:GILD (4/26/2024, 7:00:00 PM)

After market: 65.5 +0.08 (+0.12%)

65.42

+0.15 (+0.23%)

GILD News

News Image17 hours ago - Market News VideoJune 7th Options Now Available For Gilead Sciences (GILD)
News Image17 hours ago - InvestorPlace3 Dividend Stocks to Buy at a 52-Week Low in April

Explore these three dividend stocks trading near their 52-week lows, presenting compelling opportunities for income-oriented investors.

News Image21 hours ago - Gilead Sciences, Inc.FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
News Imagea day ago - The Motley FoolGilead Sciences (GILD) Q1 2024 Earnings Call Transcript

GILD earnings call for the period ending March 31, 2024.

News Imagea day ago - InvestorPlaceGILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q1 2024

GILD stock results show that Gilead Sciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

News Imagea day ago - BusinessInsiderGILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Gilead Sciences (NASDAQ:GILD) just reported results for the first quarter of 20...

News Imagea day ago - ChartmillCurious about which S&P500 stocks are showing activity after the closing bell on Thursday?

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top S&P500 gainers and losers in today's after hours session.

News Image2 days ago - Investor's Business DailyWill Gilead's Big Veklury Beat Offset A Cancer Drug Miss?

Gilead beat first-quarter calls, but it came on the back of Covid drug Veklury.

News Image2 days ago - Gilead Sciences, Inc.Gilead Sciences Announces First Quarter 2024 Financial Results
News Image2 days ago - Market News VideoNoteworthy Thursday Option Activity: NEM, GILD, GOOG
News Image10 days ago - ChartmillWhy the dividend investor may take a look at NASDAQ:GILD.

Uncovering Dividend Opportunities with GILEAD SCIENCES INC (NASDAQ:GILD).

GILD Links
Follow us for more